BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
42.13
0.40 (0.96%)
At close: Jun 23, 2025, 3:59 PM
42.17
0.11%
After-hours: Jun 23, 2025, 07:40 PM EDT
0.96% (1D)
| Bid | 42.06 |
| Market Cap | 8B |
| Revenue (ttm) | 127.42M |
| Net Income (ttm) | -667.97M |
| EPS (ttm) | -3.56 |
| PE Ratio (ttm) | -11.83 |
| Forward PE | -23.29 |
| Analyst | Buy |
| Ask | 42.5 |
| Volume | 1,979,150 |
| Avg. Volume (20D) | 2,969,162 |
| Open | 41.32 |
| Previous Close | 41.73 |
| Day's Range | 41.32 - 42.20 |
| 52-Week Range | 21.62 - 42.20 |
| Beta | 1.10 |
About BBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
BridgeBio Pharma Inc. is scheduled to release its earnings on Jul 31, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+5.33%
BridgeBio Pharma shares are trading higher after t...
Unlock content with
Pro Subscription
1 month ago
+1.48%
BridgeBio Pharma shares are trading higher after the company reported better-than-expected Q1 financial results.
